Overview
Erlocip 150 mg contains Erlotinib, an oral cancer medication that targets specific proteins involved in cancer cell growth. It is used mainly for the treatment of non-small cell lung cancer (NSCLC) and advanced pancreatic cancer. Erlotinib belongs to a class of drugs called epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, and it works by blocking the signals that encourage cancer cell proliferation.





